Skip to content

Clinical trials

Lung Diseases, Obstructive trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Obstructive Country / region: Canada Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20101
20131
20143
20153
20164
20172
20181
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca11
West Park Healthcare Centre2
Altair Therapeutics, Inc.1
Jasper Therapeutics, Inc.1
Laval University1
Novartis1
University of Alberta1
University of British Columbia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Obstructive19
Lung Diseases13
Asthma12
Bronchial Diseases12
Respiratory Tract Diseases12
Pulmonary Disease, Chronic Obstructive6
Hypersensitivity4
Hypersensitivity, Immediate4
Immune System Diseases4
Respiratory Hypersensitivity3

Trials

Showing 76 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.